NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]
Company maintains safe and successful operations through the pandemicSchool closures drive revenue declines in second quarter and year-to-dateOperating results turn […]